Progressive conditions, such as cicatrising conjunctivitis may require lifelong immunosuppression, but patients with NIU and Scleritis and those on CTSS, immunosuppression withdrawal should be considered if they remain in remission for 2 years. Any patient stopping a medication should be contacted immediately for counselling. These data will better inform patients, encourage adherence and aide formal guideline development.
Keyphrases
- end stage renal disease
- ejection fraction
- chronic kidney disease
- multiple sclerosis
- newly diagnosed
- healthcare
- oxidative stress
- prognostic factors
- electronic health record
- type diabetes
- case report
- metabolic syndrome
- skeletal muscle
- adverse drug
- glycemic control
- adipose tissue
- systemic lupus erythematosus
- hiv infected
- insulin resistance
- deep learning
- human immunodeficiency virus
- artificial intelligence
- antiretroviral therapy
- drug induced